Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 Years of experience

Journal of Endovascular Therapy

Volumn 13, Issue 3, 2006, Pages 281-290

  Fischer, Matthias ^a,b   Schwabe, Claudia ^a   Schulte, Karl Ludwig ^a  

^a Ev Hospital Königin Elisabeth   (Germany)

^b Vascular Medicine Berlin Helle Mitte   (Germany)

Author keywords

Occlusion; Peripheral occlusive disease; Stenosis; Stent graft; Superficial femoral artery; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY OCCLUSION; ARTERY PROSTHESIS; ARTERY REOCCLUSION; ARTICLE; ASPIRATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; CALCIFICATION; DEVICE; DISEASE CLASSIFICATION; ENDOPROSTHESIS; FALSE ANEURYSM; FEMALE; FEVER; FOLLOW UP; HEMATOMA; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PAIN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RUTHERFORD CLASSIFICATION; STENT; SUPERFICIAL FEMORAL ARTERY; THROMBOEMBOLISM; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHRONIC DISEASE; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; STENTS; THROMBOEMBOLISM; VASCULAR PATENCY;

EID: 33751193473     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/05-1799.1     Document Type: Article

References (43)

1. Do DD, Thriller J, Walpoth BH, et al. A comparison study of self-expandable stents vs. balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol. 1992;15:306-312.
2. Henry M, Amor M, Ethevenot G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology. 1995;197:167-174.
3. Martin EC, Katzen BT, Benanti JF, et al. Multicenter trial of the Wallstent in iliac and femoral arteries. J Vasc Interv Radiol. 1995;6:843-849.
4. Sapoval MR, Long AL, Raynaud AC, et al. Femoropopliteal stent placement: long-term results. Radiology. 1992;184:833-839.
5. Strecker EP, Boos IB, Gottmann D. Femoropopliteal artery stent placement: evaluation of long-term success. Radiology. 1997;205:375-383.
6. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent in femoropopliteal obstructions: a multicenter prospective randomised study. J Vasc Interv Radiol. 2001;12:23-31.
7. Muradin GS, Bosch JL, Stijnen T, et al. Balloon dilatation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology. 2001;221:137-145.
8. Vroegindeweij D, Vos LD, Tielbek AV, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomised study. Cardiovasc Intervent Radiol. 1997;20:420-425.
9. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
10. Diethrich EB, Papazoglou K. Endoluminal grafting for aneurysmal and occlusive disease in the femoropopliteal arteries: early experience. J Endovasc Surg. 1995;2:225-239.
11. Henry M, Amor M, Ethevenot G, et al. Initial experience with the Cragg Endopro System I in the interventional treatment of peripheral vascular disease. J Endovasc Surg. 1994;1:31-43.
12. Kessel DO, Wijesinghe LD, Robertson I, et al. Endovascular stent-grafts for superficial femoral artery disease: results of 1-year follow-up. J Vasc Interv Radiol. 1999;10:289-296.
13. Rodriguez-Lopez JA, Soler L, Werner A, et al. Long-term follow-up of endoluminal grafting for aneurysmal and occlusive disease in the superficial femoral artery. J Endovasc Surg. 1999;6:270-277.
14. Spoelstra H, Casselman F, Lesceu O. Balloon-expandable endobypass for femoropopliteal atherosclerotic occlusive disease. J Vasc Surg. 1996;24:647-654.
15. Lammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000;217:95-104.
16. Clark TW, Groffsky JL, Soulen MC. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol. 2001;12:923-933.
17. Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up. Radiology. 1994;191:727-733.
18. Schillinger M, Exner M, Mlekusch W, et al. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther. 2002;9:59-66.
19. Clowes AW, Clowes MM, Fingerle J, et al. Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol. 1989;14(suppl6):S12-S15.
20. Golden MA, Hanson SR, Kirkman TR, et al. Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg. 1990;11:641-649.
21. Virmani R, Kolodgie FD, Dake MD, et al. Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries. J Vasc Interv Radiol. 1999;10:445-456.
22. Takenaka K, Kholoussy AM, Yang Y, et al. The healing of the thin-walled expanded polytetrafluoroethylene vascular graft. Vasc Surg. 1985;19:383-389.
23. Ombrellaro MP, Stevens SL, Sciarrotta J, et al. Effect of balloon-expandable and self-expanding stent fixation on endoluminal polytetrafluoroethylene graft healing. Am J Surg. 1997;173:461-466.
24. Hagenaars T, Gussenhoven EJ, Smeets L, et al. Midterm follow-up of balloon-expandable ePTFE endografts in the femoropopliteal segment. J Endovasc Ther. 2002;9:428-435.
25. Henry M, Amor M, Cragg A, et al. Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system. Radiology. 1996;201:717-724.
26. Cragg AH, Dake MD. Treatment of peripheral vascular disease with stent-grafts. Radiology. 1997;205:307-314.
27. Hofmann M, Farber A, Fischer M, et al. Stent-graft-implantation in superficial femoral artery-a promising therapy? [in German]. Gefäßchirurgie. 2001;6:S25-S29.
28. Hunink MG, Wong JB, Donaldson MC, et al. Revascularization for femoropopliteal disease: a decision and cost-effectiveness analysis. JAMA. 1995;274:165-171.
29. Patterson RB, Fowl RJ, Kempczinski RF, et al. Preferential use of ePTFE for above-knee femoropopliteal bypass grafts. Ann Vasc Surg. 1990;4:338-343.
30. Prendiville EJ, Yeager A, O'Donnell TF, et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg. 1990;11:517-524.
31. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14:303-311.
32. Jahnke T, Andresen R, Muller-Hulsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol. 2003;14:41-51.
33. Deutschmann HA, Schedlbauer P, Berczi V, et al. Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol. 2001;12:943-950.
34. Ohki T, Marin ML, Veith FJ, et al. Anastomotic intimal hyperplasia: a comparison between conventional and endovascular stent graft techniques. J Surg Res. 1997;69:255-267.
35. Fillinger MF, Reinitz ER, Schwartz RA, et al. Graft geometry and venous intimal-medial hyperplasia in arteriovenous loop grafts. J Vasc Surg. 1990;11:556-566.
36. The CLASSIC Study: clopidogrel plus ASA vs. ticlopidine plus ASA in stent-patients [in German]. Z Kardiol. 1999;88(5 Suppl):1-4.
37. Hartung O, Otero A, Dubuc M, et al. Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants. Eur J Vasc Endovasc Surg. 2005;30:300-306.
38. Duda SH, Bosiers M, Pusich B, et al. Endovascular treatment of peripheral artery disease with expanded PTFE-covered nitinol stents: interim analysis from a prospective controlled study. Cardiovasc Intervent Radiol. 2002;25:413-418.
39. Wiesinger B, Beregi JP, Oliva VL, et al. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenosis and occlusions: final results from a prospective study. J Endovasc Ther. 2005;12:240-246.
40. Ahmadi R, Schillinger M, Maca T, et al. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology. 2002;223:345-350.
41. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338.
42. Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol. 2004;7:2-5.
43. Woody JD, Nishanian G, Kopchok GE, et al. Healing response of normal canine aorta and iliac artery to a nitinol stent encapsulated in carbon-lined ePTFE. J Endovasc Ther. 2001;8:274-281.